Connect with us

News

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm’s history

gbafNews28

– The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates

In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies and diagnostic companies

MUNICH and MONTREAL, Oct. 27, 2020 /PRNewswire/ — TVM Capital Life Science, one of the leading life sciences venture capital firms in North America and Europe, today announced the final closing of its latest fund, TVM Life Science Innovation II (TVM LSI II). Committed capital totals US$478 million which was raised from high profile international investors, including Eli Lilly and Company, other strategic investors, pension funds, endowments, foundations, fund-of-funds, wealth managers and large US banks as well as multi and single family offices from the Americas, Europe and South Korea. The geographical focus for the Fund’s investment activity is on North-America and Europe.

TVM LSI II was substantially oversubscribed. The Fund already sold its first investment in February 2020.

TVM LSI II will maintain TVM’s focus on investing in assets that provide a visible and attractive exit strategy from the outset with the goal of maximizing returns and providing early and significant liquidity for its investors. About 50-60% of the Fund’s capital is intended to be invested in "Project Focused Companies" ("PFCs") which are majority-owned by the Fund and set up for the development of early-stage drug candidates in a capital and time efficient manner. The remaining capital will be invested in late clinical stage biopharmaceutical companies as well as commercial stage medical device and diagnostic companies. The proven focus of TVM LSI II continues on building a portfolio of differentiated first-in-class and best-in-class assets that are diversified by indication and stage of development.

Dr. Luc Marengere, Managing Partner of TVM Capital Life Science commented: "We are thrilled by the strong support of existing and new investors in TVM LSI II. TVM LSI II is the largest fund raised by TVM since inception. In addition, we are grateful for the pivotal role in raising TVM LSI II in the Americas and Europe by New York based OCP and Founder Joelle Wyser-Pratte."

Stefan Fischer, Managing Partner (Finance) stated: "We are confident that TVM LSI II will not only continue the TVM success story for our investors but will also enable the financing of the development of new and differentiated treatment options for patients with significant unmet medical needs."

"The success of this fundraising effort is a strong validation of the innovative, capital-efficient investment strategy that we have implemented in 2012 together with Eli Lilly and Company. TVM LSI II intends to make investments in about 16 early-stage single asset PFCs and 10 late-stage companies with a focus on North America and Europe," wrote Dr. Hubert Birner, Managing Partner of TVM Capital Life Science based in Munich.

With the closing of TVM LSI II, Stefan Fischer was promoted to Managing Partner (Finance) and Dr. Sascha Berger was promoted to Partner.

In the past few months, the TVM investment team was complemented with the addition of Alexandra MacLean, MD and Alain Thibault, MD as Principals and, Dr. Valentina Agostina, Catello Somma and Philipp Lechner as Associates.

About TVM Capital Life Science

TVM Capital Life Science provides venture capital to international biopharmaceutical, medical technology, and diagnostic companies in North America and the EU. TVM follows a two-pronged strategy with a focus on early and late stage investments.

www.tvm-lifescience.com.

Contacts:

Media/Press:
TVM Capital Life Science: Stefan Fischer, Managing Partner (Finance), TVM Capital Life Science, [email protected], +49 89 998 992 36

Investors:
OCP Capital: Joelle Wyser-Pratte, Founder, [email protected], +1 914 441 3554

General Partner
TVM Life Science Innovation II (GP) S. à r.l.
8, Rue Lou Hemmer
L-1748, Senningerberg
Grand Duchy of Luxembourg

Investment Advisor
TVM Life Science Management Inc.
2 Place Alexis Nihon, Suite 902, Montréal, QC H3Z 1X5, Canada

TVM Life Science Management GmbH
Ottostrasse 4
80333 Munich
Germany

Logo – https://mma.prnasia.com/media2/1319854/TVM_Capital_Life_Science_Logo.jpg?p=medium600

Related Links :

https://www.tvm-lifescience.com

News

BlackRock Unveils New Offering to Power Investors’ Transition to Net Zero Emissions

gbafNews28

Building on BlackRocks strength in risk management through the Aladdin platform, BlackRock today announced it has created Aladdin Climate to meet the urgent need among financial institutions and investors to quantify climate risk in their portfolios as the physical toll of climate change mounts and the global transition to net zero emissions accelerates.

Aladdin Climate is the first software application to offer investors measures of both the physical risk of climate change and the transition risk to a low-carbon economy on portfolios with climate-adjusted security valuations and risk metrics. Using Aladdin Climate, investors can now analyze climate risk and opportunities at the security level and measure the impact of policy changes, technology, and energy supply on specific investments. Aladdin Climate is initially available as an add-on for existing Aladdin clients globally with asset class coverage rolled out gradually over the course of 2021.

There is no single issue that clients ask us more about than the impact of climate risk on their portfolio, said Rob Goldstein, BlackRocks Chief Operating Officer. Yet, while lots of people are talking about climate risk today, what investors need to make informed decisions is data tied to specific securities in their portfolio. Aladdin Climate is a dramatic step forward to begin filling the information gap necessary to build truly sustainable portfolios.

Evolution of ESG Data

Investors have long highlighted the need for improved ESG data to increase sustainable investing strategies. Now, the dramatic growth in relevant corporate disclosures and unstructured data has created unprecedented opportunities to enhance climate analytics. Today, more than 85% of S&P 500 companies disclose ESG data, compared to 20% ten years ago and Sustainability Accounting Standards Boards (SASB) disclosures have increased 288% since January.

More and more organizations seek to report on climate risk, whether for mandatory stress tests or voluntary disclosures such as the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, but have lacked tools that quantify climate risk. Aladdin Climate will help clients stress test investments to estimate how they might perform in different climate scenarios like those outlined in the Paris Agreement.

We are building on BlackRocks strength in financial modeling and risk management to set a standard for climate risk analytics, said Mary-Catherine Lader, Head of Aladdin Sustainability at BlackRock. Aladdin Climate analyzes climate risk alongside traditional risk metrics for a holistic view of risk across the investment process, all integrated in existing Aladdin workflows. Investors can now analyze tough questions about rising sea levels potential impact on their portfolios, or how a rapid shift to low-carbon policies could affect specific companies.

Partnerships with Sustainalytics and Refinitiv

BlackRock has also expanded access to ESG data through new partnerships with leading data providers Sustainalytics and Refinitiv. Aladdin now offers over 1,200 key performance indicators to help portfolio and risk managers identify sustainability-related risks in their exposures and make informed asset allocation decisions. By providing all Aladdin clients a set of ESG scores across a broad universe of companies, BlackRock is making it easier for investors to incorporate ESG metrics in their investment process.

About Aladdin Aladdin is BlackRocks end-to-end investment management and operations platform used by institutional investors including asset managers, pension funds, insurers and corporate treasurers. It combines sophisticated risk analytics with comprehensive portfolio management, trading and operations tools on a single, unified platform. Also customized for wealth managers, Aladdin provides a common language across the investment lifecycle and enables a culture of risk transparency among users.

Logan Koffler

[email protected]

646.231.1904

Continue Reading

News

Viseon MaxView™ System Accelerates Adoption of Minimally Invasive Spine Surgery Procedures

gbafNews28

Viseon, Inc., a leader in minimally invasive spine surgery visualization technologies, today announced MaxView„¢ facilitates more rapid adoption of Minimally Invasive Spine Surgery procedures by providing an enhanced teaching and learning experience. MaxView„¢ is a state-of-the-art technology that provides a first-of-its-kind, unobstructed view into Minimally Invasive Spine Surgery procedures. This intraoperative view of the surgical site is displayed in high definition onto operating room monitors, allowing for a magnified see and be seen experience. Surgeon trainees now have the ability to observe the procedure in real time and trainers have the confidence to allow trainees to perform a greater portion of the surgery earlier in their training, intervening only when necessary. Gregory Mundis, MD, Co-Director of the San Diego Spine Fellowship Program at Scripps Green Hospital and Rady Childrens Hospital, commented, Viseons MaxView„¢ has enabled me to let go of the knife and trust my fellows months earlier in their training. They get to see very early in their training how I perform the procedures and subsequently I am able to directly observe and direct their hands through MaxView„¢ video assistance.

Teaching and learning Minimally Invasive Spine Surgery procedures has historically been challenging for many reasons, all of which remain barriers to adoption. The most significant challenge to adoption of these procedures is limited visualization, being that only one person can view the surgical site at any given time. As a result, many trainees leave residency, fellowship or industry-sponsored training with a lack of confidence to adopt the procedure in their practice. Learning a procedure and adopting a procedure are two totally different things. For the first time ever, MaxView„¢ is enhancing the trainer and trainee experience, ultimately resulting in surgeon confidence and increased adoption rates of Minimally Invasive Spine Surgery procedures, stated Matt Anderson, Viseon Vice President US Sales. As profound as it may sound, the surgeons enhanced ability to see accelerates adoption of advanced techniques, improves OR efficiency and minimizes risks of complications, added Mr. Anderson. The MaxView„¢ System provides superior visualization through minimally invasive access that is unobstructed by instrument handles and surgeon hands, and projects a real-time image onto the OR monitor, allowing the entire OR team to observe the highly magnified HD views. As a result, trainees leave training programs with a superior experience and increased confidence to more rapidly adopt advanced procedures into their practice.

About Viseon, Inc.

Viseon has developed a unique portfolio of devices to improve the procedural and clinical outcomes of many Minimally Invasive Spine Surgery procedures. In addition to rapid product development of its products, Viseon has assembled a world-class Clinical Advisory Board of leading MISS physicians, amassed a significant intellectual property portfolio, completed a large series of clinical use and is currently in phase-one of US commercialization. Viseon is a privately held medical device company founded in early 2017 as a spin-out from Rebound Therapeutics Corporation, and is located in Irvine, California.

Viseon, Inc.

Matt Anderson, VP Sales

949-662-3959

www.ViseonSpine.com

https://www.linkedin.com/company/viseon-spine

Continue Reading

News

Centripetal Ranked Number 124 of the Fastest Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™

gbafNews28

Centripetal today announced it ranked 124th on Deloittes Technology Fast 500„¢, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, and energy tech companies in North America now in its 26th year. Centripetal grew 957 percent during this period. Centripetals chief executive officer, Steven Rogers, credits the companys highly advanced CleanINTERNET solution for their revenue growth.

We are pleased, for the second year in a row, to be part of the Fastest-Growing Companies in North America on Deloittes Technology Fast 500 list, said Steven Rogers, CEO of Centripetal. Our success is due to our dedicated team. They continue to develop and deliver our customer-focused solution “ CleanINTERNET. As cyber threats become more complex all organizations can take the upper hand and rely on our team for proactive use intelligence driven services. That value has resulted in exceptional growth for Centripetal.

Centripetal with its CleanINTERNET offering is revolutionary in its ability to leverage mass-scale intelligence to protect an organizations network operations. Centripetals team is composed of data scientists, engineers, mathematicians, and seasoned cybersecurity professionals from the private sector and the U.S. intelligence & Defense communities. Centripetals team has secured and protected many of the most sensitive communications assets in the world. Centripetal takes pride in providing intelligence solutions as a client-specific service to safeguard the organization as a whole, its employees, and partners.

For more than 25 years, weve been honoring companies that define the cutting edge and this years Technology Fast 500 list is proof positive that technology from software and digital media platforms, to biotech truly does permeate so many facets of our lives, said Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader. We congratulate this years winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic.

Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive, said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloittes audit and assurance practice. We extend sincere congratulations to these well-deserved winners who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible.

Centripetal previously ranked 93 as a Technology Fast 500„¢ award winner for 2019.

Overall, 2020 Technology Fast 500„¢ companies achieved revenue growth ranging from 175% to 106,508% from 2016 to 2019, with median growth of 450%.

About Deloittes 2020 Technology Fast 500„¢

Now in its 26th year, Deloittes Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies both public and private in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.

About Centripetal

Centripetal delivers intelligence-driven security. Centripetal invented the Threat Intelligence Gateway and leverages its technologies to deliver CleanINTERNET, a comprehensive intelligence-led cyber service. With Centripetal, customers across every vertical and of every size can persistently prevent over 90% of known threats with intelligence applied in advance. Gartner, Inc. previously named Centripetal a “Cool Vendor” in security for 2017, the Security Innovation Network (SINET) named Centripetal a SINET-16 awardee, and was ranked number 124 of the Fastest Growing Companies in North America on Deloittes 2020 Technology Fast 500„¢. In 2019 Centripetal was ranked #93 on the Deloitte Fast 500. Centripetals technology is protected by over 50 US and international patents and is deployed protecting critical networks globally. For more information, visit www.centripetal.ai.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (DTTL), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as Deloitte Global) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the Deloitte name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

Copyright 2020 Centripetal Networks Inc. All rights reserved. CleanINTERNET, RuleGATE, QuickThreat, AI-Analyst, ACT, and the Centripetal design are registered trademarks of Centripetal Networks Inc. Centripetals products and technologies are covered by multiple U.S. and international patents. For a full list and for more information, please visit www.centripetal.ai/legal. All other names and trademarks are property of their respective owners.

Centripetal Corporate Contact:

Byron Rashed

Centripetal Networks Inc.

+1 571 252 5080 Main

+1 571 252 5084 Direct

[email protected]

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News30 mins ago

Centripetal Ranked Number 124 of the Fastest Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™

Centripetal today announced it ranked 124th on Deloittes Technology Fast 500„¢, a ranking of the 500 fastest growing technology, media,...

gbafNews28 gbafNews28
News30 mins ago

Viseon MaxView™ System Accelerates Adoption of Minimally Invasive Spine Surgery Procedures

Viseon, Inc., a leader in minimally invasive spine surgery visualization technologies, today announced MaxView„¢ facilitates more rapid adoption of Minimally...

gbafNews28 gbafNews28
News30 mins ago

BlackRock Unveils New Offering to Power Investors’ Transition to Net Zero Emissions

Building on BlackRocks strength in risk management through the Aladdin platform, BlackRock today announced it has created Aladdin Climate to...

gbafNews28 gbafNews28
News30 mins ago

Kount Partners With Snowflake to Deliver Actionable Customer Insights for eCommerce Providers to Improve Customer Experience, Lower Friction, Increase Conversions and Uncover Cross-sell and Upsell Opportunities

Kount, the leader in identity trust and digital fraud protection, today announced a partnership with Snowflake, provider of Data Cloud,...

gbafNews28 gbafNews28
News30 mins ago

Biodesix Publishes Extended Analyses of the Nodify XL2® Lung Nodule Test

Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of...

gbafNews28 gbafNews28
News30 mins ago

HSBC USA Observes #GivingTuesday with $400,000 In New Contributions to Feeding America, American Red Cross and to Address Evictions Crisis

HSBC Bank USA kicks off the year-end giving season with announcements on Giving Tuesday of increased contributions to organizations providing...

gbafNews28 gbafNews28
News30 mins ago

NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the development...

gbafNews28 gbafNews28
News30 mins ago

Pacific Premier Bank Makes $200,000 Grant to Susan G. Komen’s Patient Navigation Initiative for Breast Health in Orange County

Pacific Premier Bancorp, Inc. (NASDAQ: PPBI), the holding company of Pacific Premier Bank (the Bank), announced today the Bank has...

gbafNews28 gbafNews28
News30 mins ago

H.I.G. Growth Partners Completes Strategic Transaction with The Center for Digestive Health and Pinnacle GI Partners

H.I.G. Growth Partners (“H.I.G.”), the dedicated growth capital investment affiliate of H.I.G. Capital, is pleased to announce that one of...

gbafNews28 gbafNews28
News30 mins ago

DataTribe Announces Third Annual Cybersecurity Start-Up Challenge Finalists

DataTribe, a global cyber foundry that invests in and co-builds next-generation cybersecurity and data science companies, announced today the finalists...